CONSORT Extension for Reporting N-of-1 Trials (CENT 2015)
​Overview
​
The CONSORT Extension for N-of-1 Trials (CENT) 2015 provides evidence-based recommendations for reporting N-of-1 trials. CENT extends the CONSORT 2010 Statement to improve the completeness, transparency and interpretation of reports of N-of-1 trials.
What is it for?​
​
CENT is designed to help authors report N-of-1 trials clearly and completely, facilitating critical appraisal, replication and synthesis of evidence.
Who should use it?​
​
Researchers, clinicians, students, journal editors, peer reviewers and others involved in the planning, conduct, reporting and evaluation of N-of-1 trials.
Key resources​
​
The CENT guideline includes a 20-item checklist and an accompanying Explanation and Elaboration paper.
​
​
​
​
​
​​
​
​
​
​
​
​
​​
About CENT
​
Type
Reporting guideline
Published
2015
Developed by
CENT Group
Based on
CONSORT 2010
Number of items
20
Full references
​
Vohra, S., Shamseer, L., Sampson, M., Bukutu, C., Schmid, C. H., Tate, R., Nikles, J., Zucker, D. R., Kravitz, R., Guyatt, G., Altman, D. G., Moher, D., and the CENT Group. (2015). CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement. BMJ, 350, h1738.
Shamseer, L., Vohra, S., Sampson, M., Bukutu, C., Schmid, C. H., Tate, R., Nikles, J., Zucker, D. R., Kravitz, R., Guyatt, G., Altman, D. G., Moher, D., and the CENT Group. (2015). CONSORT extension for reporting N-of-1 trials (CENT) 2015: Explanation and elaboration. BMJ, 350, h1793.
​
Related Guidelines
​